• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award

    Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award

  2. Dicerna Announces the Appointment of Theodore T. Ashburn, M.D., Ph.D. to Senior Vice President, Product Strategy and Operations, and Inducement Grant of Stock Options under NASDAQ Listing Rule 5635 ...

    Dicerna Announces the Appointment of Theodore T. Ashburn, M.D., Ph.D. to Senior Vice President, Product Strategy and Operations, and Inducement Grant of Stock Options under NASDAQ Listing Rule 5635 (c)(4)

  3. Alnylam Files Clinical Trial Application (CTA) for ALN-CC5, an RNAi Therapeutic Targeting Complement C5 in Development for the Treatment of Complement-Mediated Diseases

    Alnylam Files Clinical Trial Application (CTA) for ALN-CC5, an RNAi Therapeutic Targeting Complement C5 in Development for the Treatment of Complement-Mediated Diseases

  4. Research and Markets: EU5 Wound Closure Devices Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Baxter International

    Research and Markets: EU5 Wound Closure Devices Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Baxter International

  5. Research and Markets: Fabry Disease - Pipeline Review, H2 2014

    Research and Markets: Fabry Disease - Pipeline Review, H2 2014

  6. Sanofi Shakes Off Patent Losses

    The drugmaker faces less long-term volatility as the focus shifts to steady businesses.

  7. Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection

    Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection

  8. Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch

    Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch

  9. REITs, Target Dates, Dollar-Proofing, and More

    A roundup of investment news.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.